October 10, 2019
Aerpio Pharmaceuticals encouraged phase 1b trial of topical ocular formulation for primary open angle glaucoma
Aerpio Pharmaceutical encouraged by the early safety findings and potential efficacy signal of this ongoing Phase 1b trial.